
欧洲注射笔市场预测至 2028 年 - COVID-19 影响和区域分析(按类型(一次性注射笔和可重复使用注射笔)、治疗(糖尿病、生长激素治疗、自身免疫性疾病、生育力、癌症和其他治疗)和最终用户(医院和诊所、家庭护理等)
No. of Pages: 145 | Report Code: BMIRE00028188 | Category: Life Sciences
No. of Pages: 145 | Report Code: BMIRE00028188 | Category: Life Sciences
欧洲注射笔市场慢性疾病患病率上升
< /span>
人口老龄化和社会行为的变化导致了一些常见且代价高昂的长期健康问题。据世界卫生组织 (WHO) 预测,到 2026 年,慢性生活方式疾病的患病率预计将达到 57%。随着城市化进程的加快,人们更倾向于久坐的生活方式,从而导致肥胖和糖尿病。糖尿病是21世纪最大的全球健康问题之一。在预测期内,疾病患病率预计将增加约 35%。此外,其他慢性疾病,如骨质疏松症、心血管疾病和多发性硬化症,需要频繁给药以进行治疗和疾病管理。根据世界卫生组织的数据,心血管疾病是导致死亡的主要原因。每年有近 1790 万人因心血管疾病死亡。它已成为全球大量患者群体注射给药的新标准。此外,它可以很容易地被大量患者群体使用,只需很少的培训,不需要医疗保健专业人员的持续帮助,因此注射笔在家庭医疗保健环境中被广泛采用。
  ;
欧洲注射笔市场概况
欧洲注射笔市场分为德国、法国、意大利、西班牙、英国和欧洲其他国家。该地区在全球注射笔市场中占据重要地位,预计在预测期内将实现可观的增长率。该市场的主要驱动力是生物仿制药和其他治疗药物的使用增加,以及患有糖尿病、心血管疾病、癌症和生育问题的患者数量激增。此外,家庭医疗保健和自我给药的增长趋势预计将推动注射笔市场的增长。此外,研发活动的增加和新产品的推出预计将有助于预测期内注射笔市场的增长。
欧洲注射笔市场细分
欧洲注射笔市场根据类型、治疗方法、用途进行细分用户和国家。根据类型,注射笔市场分为一次性注射笔和可重复使用注射笔。一次性注射笔细分市场在 2022 年将占据更大的市场份额。
根据治疗,欧洲注射笔市场细分为糖尿病治疗、生长激素治疗、自身免疫性疾病治疗、生育治疗、癌症治疗等。糖尿病治疗细分市场在 2022 年占据最大市场份额。
根据最终用户,欧洲注射笔市场细分为医院及诊所、家庭护理等。家庭护理细分市场在 2022 年占据最大市场份额。
根据国家/地区,欧洲注射笔市场分为德国、英国、法国、意大利、西班牙和欧洲其他国家。欧洲其他地区在 2022 年占据市场主导地位。
阿斯利康 (AstraZeneca Plc)、Becton Dickinson and Co、Eli Lilly and Co、Gerresheimer AG、Haselmeier GmbH、Merck KGaA、Novo Nordisk AS、Owen Mumford Ltd、Sanofi SA 和 Teva Pharmaceutical Industries Ltd 都是欧洲注射笔市场的领先公司。
Strategic insights for Europe Injection Pen involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 11,194.60 Million |
Market Size by 2028 | US$ 16,749.04 Million |
Global CAGR (2022 - 2028) | 6.9% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Injection Pen refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Injection Pen Market is valued at US$ 11,194.60 Million in 2022, it is projected to reach US$ 16,749.04 Million by 2028.
As per our report Europe Injection Pen Market, the market size is valued at US$ 11,194.60 Million in 2022, projecting it to reach US$ 16,749.04 Million by 2028. This translates to a CAGR of approximately 6.9% during the forecast period.
The Europe Injection Pen Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Injection Pen Market report:
The Europe Injection Pen Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Injection Pen Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Injection Pen Market value chain can benefit from the information contained in a comprehensive market report.